PATENT CLAIM ANALYSIS

Application Number: 15760878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided are polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. Further provided are compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.

Claim (Index 45):
The polypeptide according to  claim 44 , wherein the reconstituted RBM comprises:\n (a) at least one linker and wherein at least one of said linker/s replace/s said loop or any part thereof; or (b) at least one linker and wherein at least one of said linker/s replace/s at least one RBM fragment or amino acid residue/s not directly involved in receptor binding.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15306617', '10997201', '14375083', '15553466', '14717760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8090662049620848
- 35 USC 102 Novelty (BERT): 0.5595557447645849
- Combined Prediction Score: 0.7841151589423349
- Mean Citation Score: 451.928406
- Max Citation Score: 490.51212
- Similarity Product: 314.18076505617137

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test